Search for Clinical Trial Results
Leukemia, Prolymphocytic - 55 Studies Found
Status | Study |
Completed |
Study Name: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) Condition: Leukemia, Lymphocytic, Chronic Date: 2007-04-20 Interventions: Drug: alvocidib 1st dose: 30 mg/m2 as a 30-minute intraven |
Withdrawn |
Study Name: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation Condition:
Interventions: |
Active, not recruiting |
Study Name: Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia Condition:
Interventions: |
Active, not recruiting |
Study Name: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia Condition:
|
Completed |
Study Name: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia Condition: Leukemia Date: 2001-07-11 Interventions: Biological: alemtuzumab |
Completed |
Study Name: Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Condition:
Date: 2005-08-02 Interventions:
|
Active, not recruiting |
Study Name: Acalabrutinib in Combination With Obinutuzumab in Relapsed/Refractory or Untreated CLL/SLL/PLL Condition:
|
Completed |
Study Name: AZD6738 First Time in Patient Multiple Ascending Dose Study Condition:
|
Completed |
Study Name: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias Condition:
Date: 2007-05-11 Interventions:
|